Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-trifluoromethyl-4H-1,3-benzothiazin-4-one |
---|---|
Date Designated: | 03/15/2018 |
Orphan Designation: | Treatment of Tuberculosis (TB) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Klinikum der Universität München 15 Marchioninistr. München, Bayern Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-